Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05179005 · ClinicalTrials.gov registry record
RibFix Advantage™ Post-Market Follow-Up
A clinical trial, sponsored by Zimmer Biomet.
- Terminated
- Registry status
- 1
- Enrollment target
NCT05179005: Clinical Trial study, sponsored by Zimmer Biomet.
NCT05179005 is a clinical trial that was terminated before completion, run by Zimmer Biomet. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05179005 was terminated before completion, sponsored by Zimmer Biomet.
- TERMINATED
- Registry status
- 1 participants
- Enrollment target
Study Summary
To confirm safety, performance, and clinical benefits for the use of RibFix Advantage™ in the fixation, stabilization, and fusion of rib fractures and osteotomies of normal and osteoporotic bone
Primary Outcome
Number of subjects who needed surgical re-intervention related to rib fracture repair
Interventions
- DEVICE RibFix Advantage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2023-04-20 |
| Est. Completion | 2023-12-31 |
Why NCT05179005 stopped before completion
NCT05179005 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 1 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which RibFix Advantage is the first listed.
NCT05179005 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05179005 about?
NCT05179005 is a clinical study titled "RibFix Advantage™ Post-Market Follow-Up". To confirm safety, performance, and clinical benefits for the use of RibFix Advantage™ in the fixation, stabilization, and fusion of rib fractures and osteotomies of normal and osteoporotic bone
What is the current status of trial NCT05179005?
This trial is currently terminated. The enrollment target is 1 participants. The study started on 2023-04-20. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT05179005?
The interventions under investigation include: RibFix Advantage (DEVICE).
Who is sponsoring clinical trial NCT05179005?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI